Evaluation of the safety of high-dose Lactobacillus gasseri CP2305 supplementation in healthy adults: A randomized, double-blind, placebo-controlled study.
- 2026-06
- RCT · n = 95
- Toxicology reports 16
- Hajime Fuchida
- Daisuke Sawada
- Tatsuhiko Hirota
- Hiroki Miyashita
- Kazuhiko Takano
- Koji Mochizuki
- PubMed: 41756348
- DOI: 10.1016/j.toxrep.2026.102222
- High evidence
No adverse clinical findings were observed in either group... no safety concerns were identified in the physical examinations, hematology, blood biochemistry, urinalysis, or subjective symptoms.
- Effect
- Neutral
- Effect size
- Small